Susquehanna International Group’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $698K | Sell |
127,585
-153,514
| -55% | -$840K | ﹤0.01% | 3834 |
|
|
2025
Q1 | $1.77M | Buy |
281,099
+240,491
| +592% | +$1.51M | ﹤0.01% | 2461 |
|
|
2024
Q4 | $167K | Buy |
40,608
+230
| +0.6% | +$948 | ﹤0.01% | 5424 |
|
|
2024
Q3 | $135K | Buy |
+40,378
| New | +$135K | ﹤0.01% | 5002 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6611 |
|
|
2024
Q1 | – | Sell |
-17,207
| Closed | -$23.1K | – | 6588 |
|
|
2023
Q4 | $23.1K | Buy |
+17,207
| New | +$23.1K | ﹤0.01% | 5659 |
|
|
2023
Q3 | – | Sell |
-11,571
| Closed | -$27.7K | – | 6372 |
|
|
2023
Q2 | $27.7K | Sell |
11,571
-16,095
| -58% | -$38.5K | ﹤0.01% | 5315 |
|
|
2023
Q1 | $51.2K | Buy |
+27,666
| New | +$51.2K | ﹤0.01% | 5440 |
|
|
2021
Q1 | – | Sell |
-14,828
| Closed | -$36K | – | 5773 |
|
|
2020
Q4 | $36K | Buy |
+14,828
| New | +$36K | ﹤0.01% | 4646 |
|